Literature DB >> 28528403

Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study.

Sara Lindström1, Marine Germain2,3, Marta Crous-Bou4,5, Erin N Smith6,7, Pierre-Emmanuel Morange8, Astrid van Hylckama Vlieg9, Hugoline G de Haan9, Daniel Chasman10,11, Paul Ridker10,11, Jennifer Brody12, Mariza de Andrade13, John A Heit14, Weihong Tang15, Immaculata DeVivo4,5, Francine Grodstein4, Nicholas L Smith16,17,18, David Tregouet2,3, Christopher Kabrhel11,19.   

Abstract

Observational studies have shown an association between obesity and venous thromboembolism (VTE) but it is not known if observed associations are causal, due to reverse causation or confounding bias. We conducted a Mendelian Randomization study of body mass index (BMI) and VTE. We identified 95 single nucleotide polymorphisms (SNPs) that have been previously associated with BMI and assessed the association between genetically predicted high BMI and VTE leveraging data from a previously conducted GWAS within the INVENT consortium comprising a total of 7507 VTE cases and 52,632 controls of European ancestry. Five BMI SNPs were associated with VTE at P < 0.05, with the strongest association seen for the FTO SNP rs1558902 (OR 1.07, 95% CI 1.02-1.12, P = 0.005). In addition, we observed a significant association between genetically predicted BMI and VTE (OR = 1.59, 95% CI 1.30-1.93 per standard deviation increase in BMI, P = 5.8 × 10-6). Our study provides evidence for a causal relationship between high BMI and risk of VTE. Reducing obesity levels will likely result in lower incidence in VTE.

Entities:  

Mesh:

Year:  2017        PMID: 28528403      PMCID: PMC5531049          DOI: 10.1007/s00439-017-1811-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  25 in total

1.  Prevalence of Obesity Among Adults and Youth: United States, 2011-2014.

Authors:  Cynthia L Ogden; Margaret D Carroll; Cheryl D Fryar; Katherine M Flegal
Journal:  NCHS Data Brief       Date:  2015-11

2.  Impact of obesity on venous hemodynamics of the lower limbs.

Authors:  Torsten Willenberg; Anette Schumacher; Beatrice Amann-Vesti; Vincenzo Jacomella; Christoph Thalhammer; Nicolas Diehm; Iris Baumgartner; Marc Husmann
Journal:  J Vasc Surg       Date:  2010-06-23       Impact factor: 4.268

Review 3.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 4.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

5.  Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity.

Authors:  I Shimomura; T Funahashi; M Takahashi; K Maeda; K Kotani; T Nakamura; S Yamashita; M Miura; Y Fukuda; K Takemura; K Tokunaga; Y Matsuzawa
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

6.  Obesity as a risk factor in venous thromboembolism.

Authors:  Paul D Stein; Afzal Beemath; Ronald E Olson
Journal:  Am J Med       Date:  2005-09       Impact factor: 4.965

7.  Prospective study of BMI and the risk of pulmonary embolism in women.

Authors:  Christopher Kabrhel; Raphaëlle Varraso; Samuel Z Goldhaber; Eric B Rimm; Carlos A Camargo
Journal:  Obesity (Silver Spring)       Date:  2009-04-16       Impact factor: 5.002

8.  Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.

Authors:  Frederick A Anderson; Maxim Zayaruzny; John A Heit; Dogan Fidan; Alexander T Cohen
Journal:  Am J Hematol       Date:  2007-09       Impact factor: 10.047

Review 9.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

10.  Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.

Authors:  Jack Bowden; Fabiola Del Greco M; Cosetta Minelli; George Davey Smith; Nuala A Sheehan; John R Thompson
Journal:  Int J Epidemiol       Date:  2016-12-01       Impact factor: 7.196

View more
  16 in total

Review 1.  The genetics of adiposity.

Authors:  Ruth Jf Loos
Journal:  Curr Opin Genet Dev       Date:  2018-03-09       Impact factor: 5.578

2.  Association of Genetic Risk of Obesity with Postoperative Complications Using Mendelian Randomization.

Authors:  Jamie R Robinson; Robert J Carroll; Lisa Bastarache; Qingxia Chen; Zongyang Mou; Wei-Qi Wei; John J Connolly; Frank Mentch; Patrick Sleiman; Paul K Crane; Scott J Hebbring; Ian B Stanaway; David R Crosslin; Adam S Gordon; Elisabeth A Rosenthal; David Carrell; M Geoffrey Hayes; Wei Wei; Lynn Petukhova; Bahram Namjou; Ge Zhang; Maya S Safarova; Nephi A Walton; Christopher Still; Erwin P Bottinger; Ruth J F Loos; Shawn N Murphy; Gretchen P Jackson; Iftikhar J Kullo; Hakon Hakonarson; Gail P Jarvik; Eric B Larson; Chunhua Weng; Dan M Roden; Joshua C Denny
Journal:  World J Surg       Date:  2020-01       Impact factor: 3.352

3.  Incidence of VTE in Patients With OSA: A Cohort Study.

Authors:  Michael V Genuardi; Aman Rathore; Rachel P Ogilvie; Rebecca S DeSensi; Priya V Borker; Jared W Magnani; Sanjay R Patel
Journal:  Chest       Date:  2021-12-13       Impact factor: 9.410

Review 4.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

5.  Adiposity throughout the life course and risk of venous thromboembolism.

Authors:  Kaitlin A Hagan; Laura B Harrington; Jihye Kim; Sara Lindström; Carlos A Camargo; Francine Grodstein; Christopher Kabrhel
Journal:  Thromb Res       Date:  2018-10-26       Impact factor: 3.944

6.  Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank.

Authors:  Shan Luo; Shiu Lun Au Yeung; Jie V Zhao; Stephen Burgess; C Mary Schooling
Journal:  BMJ       Date:  2019-03-06

7.  Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis.

Authors:  Xia Jiang; Oana A Zeleznik; Sara Lindström; Jessica Lasky-Su; Kaitlin Hagan; Clary B Clish; A Heather Eliassen; Peter Kraft; Christopher Kabrhel
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

8.  Association between obesity and venous thromboembolism.

Authors:  Cristina Hotoleanu
Journal:  Med Pharm Rep       Date:  2020-04-22

9.  The EGFR-rearranged adenocarcinoma is associated with a high rate of venous thromboembolism.

Authors:  Jing Wang; Bin Hu; Tong Li; Jinbai Miao; Wenqian Zhang; Shuo Chen; Yixin Sun; Songping Cui; Hui Li
Journal:  Ann Transl Med       Date:  2019-12

10.  Cardiovascular Risk Factors Associated With Venous Thromboembolism.

Authors:  John Gregson; Stephen Kaptoge; Thomas Bolton; Lisa Pennells; Peter Willeit; Stephen Burgess; Steven Bell; Michael Sweeting; Eric B Rimm; Christopher Kabrhel; Bengt Zöller; Gerd Assmann; Vilmundur Gudnason; Aaron R Folsom; Volker Arndt; Astrid Fletcher; Paul E Norman; Børge G Nordestgaard; Akihiko Kitamura; Bakhtawar K Mahmoodi; Peter H Whincup; Matthew Knuiman; Veikko Salomaa; Christa Meisinger; Wolfgang Koenig; Maryam Kavousi; Henry Völzke; Jackie A Cooper; Toshiharu Ninomiya; Edoardo Casiglia; Beatriz Rodriguez; Yoav Ben-Shlomo; Jean-Pierre Després; Leon Simons; Elizabeth Barrett-Connor; Cecilia Björkelund; Marlene Notdurfter; Daan Kromhout; Jackie Price; Susan E Sutherland; Johan Sundström; Jussi Kauhanen; John Gallacher; Joline W J Beulens; Rachel Dankner; Cyrus Cooper; Simona Giampaoli; Jason F Deen; Agustín Gómez de la Cámara; Lewis H Kuller; Annika Rosengren; Peter J Svensson; Dorothea Nagel; Carlos J Crespo; Hermann Brenner; Juan R Albertorio-Diaz; Robert Atkins; Eric J Brunner; Martin Shipley; Inger Njølstad; Deborah A Lawlor; Yvonne T van der Schouw; Randi Marie Selmer; Maurizio Trevisan; W M Monique Verschuren; Philip Greenland; Sylvia Wassertheil-Smoller; Gordon D O Lowe; Angela M Wood; Adam S Butterworth; Simon G Thompson; John Danesh; Emanuele Di Angelantonio; Tom Meade
Journal:  JAMA Cardiol       Date:  2019-02-01       Impact factor: 14.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.